Kesson Alison M, Bellemore Michael C, O'Mara Timothy J, Ellis David H, Sorrell Tania C
Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, University of Sydney at Westmead, Australia.
Clin Infect Dis. 2009 May 1;48(9):1257-61. doi: 10.1086/597772.
We describe an 8-year-old girl who sustained multiple compound fractures in an accident involving agricultural equipment. She developed Scedosporium prolificans osteomyelitis of the pelvis, septic arthritis of the hip, and myositis of adjacent muscles. The infection progressed, despite extensive surgical debridement and joint washouts with 0.2% polyhexamethylene biguanide; antifungal therapy with caspofungin, terbinafine, and voriconazole; and adjunctive therapy with interferon-gamma. Gradual resolution was achieved after the addition of a novel agent, hexadecylphospocholine (miltefosine), and the continuation of terbinafine and voriconazole. This is the first report of the use of miltefosine as an antifungal agent in the management of severe infection with S. prolificans.
我们描述了一名8岁女孩,她在一次涉及农业设备的事故中多处发生复合性骨折。她患上了多育赛多孢菌性骨盆骨髓炎、髋部化脓性关节炎以及相邻肌肉的肌炎。尽管进行了广泛的手术清创以及用0.2%聚六亚甲基双胍进行关节冲洗,使用卡泊芬净、特比萘芬和伏立康唑进行抗真菌治疗,并使用γ-干扰素进行辅助治疗,但感染仍在进展。在加用一种新型药物十六烷基磷胆碱(米替福新)并继续使用特比萘芬和伏立康唑后,感染逐渐得到缓解。这是关于米替福新作为抗真菌药物用于治疗多育赛多孢菌严重感染的首例报道。